The new molecular safety switch technology jointly invented by Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai National Cancer Institute Cancer Gene and Related Genes Key Laboratory and Keji Biomedical (Shanghai) Co., Ltd. has made breakthroughs. The full text of the research has been published recently in the internationally renowned academic journal Molecular Therapy. This molecular safety switch technology, which integrates safety switch, genetic engineering T cell purification and detection, and has completely independent intellectual property rights, is another new breakthrough in the field of tumor immunotherapy by Koji Bio and its cooperation team. The blank of the safety switch of independent intellectual property rights in the field of cell therapy in China. “Safety switches play a very important role in the field of T cell therapy, especially in the field of CAR-T cell therapy.†Dr. Li Zonghai, the designer of the safety switch, said, “Molecular safety switching technology for CAR-T cell therapy is A very important technology that can control cell survival, thereby reducing the toxicity of T cell therapy and improving the safety of cell therapy. Currently, only a few international leading pharmaceutical companies, such as Nasdaq-listed company Bellicum pharmaceuticals, have security. Switching technology. Next we will use this technology in our CAR-T product line and conduct clinical research." Company recent news LAHOYA, CA - July 3 / CARsgen Therapeutics, which focuses on the clinical development of CAR-T cell therapy, recently announced in the US that the company has officially joined the Alliance for Regenerative Medicine (ARM) ). As the leading company in the global solid tumor CAR-T cell therapy, Koji Bio has become the first Chinese biopharmaceutical company to join the international organization. Founded in Washington in 2009, the American Regenerative Medicine Alliance is a globally influential industry alliance in the field of regenerative medicine. The organization has long been committed to scientific research, industry communication, business cooperation and regulatory regulation in the field of regenerative medicine, and is committed to promoting the worldwide promotion and popularization of regenerative medicine technology and therapy. Soybean lecithin is a natural substance that is derived from soybeans. It is a type of phospholipid, which is a molecule that is composed of two fatty acids, a phosphate group, and a nitrogen-containing base. Soybean Lecithin,Feed Supplement Soy Lecithin Powder,Professional Soybean Lecithin,Organic Soy Lecithin Powder Jiangsu Chenwei Biology and Technology Co. LTD , https://www.cwsoybean.com
Koji Biotech released the breakthrough research progress of CAR-T safety switch
Prev Article
Studies show that lack of sleep can lead to obesity